Harrow, Inc.

Contributing Author

Recent Articles by Harrow, Inc.

11 hours	Harrow Announces Closing of Acquisition of Melt Pharmaceuticals HROW GlobeNewswire
Nov-10	Harrow Announces Third Quarter 2025 Financial Results HROW GlobeNewswire
Oct-27	Harrow To Report Third Quarter 2025 Financial Results After Market Close on November 10, 2025 HROW GlobeNewswire
Oct-06	ImprimisRx Announces Leadership Changes HROW GlobeNewswire
Sep-26	Harrow to Acquire Melt Pharmaceuticals HROW GlobeNewswire
Sep-25	Harrow Launches Harrow Access for All (HAFA) HROW GlobeNewswire
Sep-15	Harrow Announces Agenda and Speakers for Investor & Analyst Day HROW GlobeNewswire
Sep-08	Harrow Announces Pricing of $250.0 Million Offering of Senior Unsecured Notes Due 2030 HROW GlobeNewswire
Sep-08	Harrow Announces Offering of $250.0 Million Senior Unsecured Notes Due 2030 HROW GlobeNewswire
Aug-11	Harrow Announces Second-Quarter 2025 Financial Results HROW GlobeNewswire
Aug-06	Harrow to Present at H.C. Wainwright 5th Annual Ophthalmology Conference HROW GlobeNewswire
Jul-29	Harrow To Report Second Quarter 2025 Financial Results After Market Close on August 11, 2025 HROW GlobeNewswire